Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-12-2023 | Cytostatic Therapy | Case report

Docetaxel

Chemotherapy-induced peripheral neuropathy: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Park K, et al. Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei Medical Journal 64 : 86-93, No. 2, Feb 2023. Available from: URL: http://doi.org/10.3349/ymj.2022.0244 Park K, et al. Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice. Yonsei Medical Journal 64 : 86-93, No. 2, Feb 2023. Available from: URL: http://​doi.​org/​10.​3349/​ymj.​2022.​0244
Metadata
Title
Docetaxel
Chemotherapy-induced peripheral neuropathy: case report
Publication date
01-12-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50967-7

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Antineoplastics

Case report

Zoledronic-acid

Case report

Carfilzomib

Case report

Asfotase-alfa